Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02575339
Title MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bert O'Neil, MD
Indications

hepatocellular carcinoma

Therapies

Sorafenib

Sapanisertib

Age Groups: adult
Covered Countries USA


No variant requirements are available.